Literature DB >> 26496752

Progress of application and off-target effects of CRISPR/Cas9.

Wu Zheng1, Feng Gu1.   

Abstract

The clustered regulatory interspaced short palindromic repeat/Cas9 (CRISPR/Cas9) system mediates genome editing and is revolutionizing genetic researches. Scientists are able to manipulate the gene of interest from any organism with CRISPR/Cas9. Compared with zinc finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs) technologies, the CRISPR/Cas9 technology provides an easy and efficient approach to manipulate the genome. In this system, sgRNA (Single guide RNA), a short RNA matching the targeted DNA fragment, guides the CRISPR/Cas9 to interrogate the genome. Because sgRNA can tolerate certain mismatches to the DNA targets and thereby promote undesired off-target mutagenesis, the key limit of this technology is off-target effects. To eliminate the off-target effects, different strategies have been adopted. In this review, we summarize the application of CRISPR/Cas9 and different strategies for addressing off-target effects.

Mesh:

Substances:

Year:  2015        PMID: 26496752     DOI: 10.16288/j.yczz.15-070

Source DB:  PubMed          Journal:  Yi Chuan        ISSN: 0253-9772


  4 in total

Review 1.  [Ex vivo stem cell gene therapy of the skin : Ready for clinical use?]

Authors:  Ulrich Koller
Journal:  Hautarzt       Date:  2020-02       Impact factor: 0.751

2.  COL7A1 Editing via CRISPR/Cas9 in Recessive Dystrophic Epidermolysis Bullosa.

Authors:  Stefan Hainzl; Patricia Peking; Thomas Kocher; Eva M Murauer; Fernando Larcher; Marcela Del Rio; Blanca Duarte; Markus Steiner; Alfred Klausegger; Johann W Bauer; Julia Reichelt; Ulrich Koller
Journal:  Mol Ther       Date:  2017-07-13       Impact factor: 11.454

3.  Cut and Paste: Efficient Homology-Directed Repair of a Dominant Negative KRT14 Mutation via CRISPR/Cas9 Nickases.

Authors:  Thomas Kocher; Patricia Peking; Alfred Klausegger; Eva Maria Murauer; Josefina Piñón Hofbauer; Verena Wally; Thomas Lettner; Stefan Hainzl; Michael Ablinger; Johann Wolfgang Bauer; Julia Reichelt; Ulrich Koller
Journal:  Mol Ther       Date:  2017-08-24       Impact factor: 11.454

4.  Plants Developed by New Genetic Modification Techniques-Comparison of Existing Regulatory Frameworks in the EU and Non-EU Countries.

Authors:  Michael F Eckerstorfer; Margret Engelhard; Andreas Heissenberger; Samson Simon; Hanka Teichmann
Journal:  Front Bioeng Biotechnol       Date:  2019-02-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.